tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
US Market
ABUS
Arbutus Biopharma
RESEARCH TOOLSreports
Want to see ABUS full AI Analyst Report?

Arbutus Biopharma (ABUS) Financial Statements

1,272 Followers

Arbutus Biopharma Financial Overview

Arbutus Biopharma's market cap is currently $827.15M. The company's EPS TTM is $; its P/E ratio is -27.51; Arbutus Biopharma is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 14.08M$ 6.17M$ 18.14M$ 39.02M$ 10.99M
Gross Profit$ 13.72M$ 6.17M$ 18.14M$ 39.02M$ 10.99M
Operating Income$ -27.05M$ -76.32M$ -78.10M$ -65.46M$ -73.52M
EBITDA$ -26.69M$ -68.40M$ -70.99M$ -61.86M$ -71.64M
Net Income$ -33.50M$ -69.92M$ -72.85M$ -69.46M$ -76.25M
Balance Sheet
Cash & Short-Term Investments$ 91.47M$ 122.62M$ 126.00M$ 146.91M$ 155.32M
Total Assets$ 94.62M$ 131.71M$ 144.40M$ 195.42M$ 204.49M
Total Debt$ 4.19M$ 1.29M$ 8.72M$ 12.55M$ 18.91M
Net Debt$ -13.82M$ -35.04M$ -17.56M$ -18.22M$ -90.37M
Total Liabilities$ 18.04M$ 34.34M$ 38.38M$ 58.57M$ 35.05M
Stockholders' Equity$ 76.58M$ 97.37M$ 106.02M$ 136.85M$ 169.44M
Cash Flow
Free Cash Flow$ -39.64M$ -65.03M$ -86.94M$ -35.87M$ -68.34M
Operating Cash Flow$ -39.64M$ -64.85M$ -85.94M$ -35.36M$ -67.53M
Investing Cash Flow$ 15.58M$ 22.95M$ 50.77M$ -74.94M$ -12.68M
Financing Cash Flow$ 5.72M$ 52.00M$ 30.65M$ 31.81M$ 137.24M
Currency in USD

Arbutus Biopharma Earnings and Revenue History

Income Statement >

Arbutus Biopharma Debt to Assets

Balance Sheet >

Arbutus Biopharma Cash Flow

Cash Flow >

Arbutus Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >